Musculoskeletal ingredient supports bone, muscle, and joint health, launching at SupplySide West
The ingredient is a blend of type I and type II collagen, calcium, phosphorus, and glycosaminoglycans-ingredients that support bone, muscle, and joint health.
Photo © Shutterstock.com/triocean
Waitaki Biosciences (Christchurch, New Zealand) is launching a new musculoskeletal ingredient at SupplySide West called CytoC. The ingredient is a blend of type I and type II collagen, calcium, phosphorus, and glycosaminoglycans-ingredients that support bone, muscle, and joint health.
During the show, the company will also highlight its other branded ingredients, all of which utilize New Zealand–grown raw materials, which the company says offer high levels of bioactives due to the region’s growing environment. These ingredients include digestive-health green kiwifruit ingredient ActiPhen and CassiPure, a blackcurrant extract high in anthocyanins. Another ingredient is PernaTec, a greenshell mussel oil extract high in phospholipids for anti-inflammatory support.
Learn more at SupplySide West Booth # 3153.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
